Docetaxel-induced scleroderma: a case report and its role in the production of extracellular matrix

Int J Rheum Dis. 2017 Nov;20(11):1835-1837. doi: 10.1111/1756-185X.12697. Epub 2015 Jul 14.

Authors

Jian-Qiang Yang¹, Ting-Ting Dou¹, Xi-Bei Chen¹, Min Min¹, Sui-Qing Cai¹, Min Zheng¹, Xiao-Yong Man¹

Affiliation

¹ Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

PMID: 26179887
DOI: 10.1111/1756-185X.12697

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / adverse effects*
Breast Neoplasms / drug therapy*
Breast Neoplasms / pathology
Carcinoma, Ductal, Breast / drug therapy*
Carcinoma, Ductal, Breast / pathology
Cells, Cultured
Chemotherapy, Adjuvant / adverse effects
Docetaxel / adverse effects*
Extracellular Matrix / drug effects*
Extracellular Matrix / metabolism
Extracellular Matrix / pathology
Extracellular Matrix Proteins / metabolism
Female
Fibroblasts / drug effects
Fibroblasts / metabolism
Fibroblasts / pathology
Fibrosis
Humans
Middle Aged
Scleroderma, Diffuse / chemically induced*
Scleroderma, Diffuse / diagnosis
Scleroderma, Diffuse / drug therapy
Scleroderma, Diffuse / metabolism
Skin / drug effects*
Skin / metabolism
Skin / pathology

Substances

Antineoplastic Agents
Extracellular Matrix Proteins
Docetaxel